Anti Xa activity and prothrombinase inhibition in patients treated with two different doses of enoxaparin in gynecologic surgery
- 31 December 1991
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 61, 29-37
- https://doi.org/10.1016/0049-3848(91)90401-h
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Inhibition of the early stages of the thrombin generation reaction by various glycosaminoglycansThrombosis Research, 1990
- The inhibition of intrinsic prothrombinase and its generation by heparin and four derivatives in prothrombin poor plasmaThrombosis Research, 1990
- Clinical Studies with Low Molecular Weight Heparins in the Prevention and Treatment of Venous ThromboembolismAnnals of the New York Academy of Sciences, 1989
- The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mgThe Journal of Clinical Pharmacology, 1988
- Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosisBritish Journal of Surgery, 1988
- The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparinBiochemical Journal, 1987
- Adjusted versus Fixed-Dose Subcutaneous Heparin in the Prevention of Deep-Vein Thrombosis after Total Hip ReplacementNew England Journal of Medicine, 1983
- VENOUS THROMBOEMBOLISM ASSOCIATED WITH GYNECOLOGIC SURGERYClinical Obstetrics and Gynecology, 1980
- LOW DOSES OF SUBCUTANEOUS HEPARIN IN THE PREVENTION OF DEEP VEIN THROMBOSIS AFTER GYNAECOLOGICAL SURGERYBJOG: An International Journal of Obstetrics and Gynaecology, 1973